In T2DM patients, TFs were found to upregulate the mRNA and protein expression of sirtuin1 (SIRT1), thereby enhancing insulin sensitivity, inhibiting hyperglycemia, and reducing oxidative stress [84]. This evidence concerns the gene INS and type 2 diabetes mellitus.